• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制补体 C3 信号转导可改善自身免疫性炎症疾病的运动和视觉功能障碍。

Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases.

机构信息

Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, Guangdong Province 510630, China.

Department of Medical Retina and Neuro-Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province 510060, China.

出版信息

Mol Ther. 2023 Sep 6;31(9):2715-2733. doi: 10.1016/j.ymthe.2023.07.017. Epub 2023 Jul 22.

DOI:10.1016/j.ymthe.2023.07.017
PMID:37481702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10492028/
Abstract

Neuromyelitis optica (NMO) is an autoimmune inflammatory disease of the central nervous system (CNS) characterized by transverse myelitis and optic neuritis. The pathogenic serum IgG antibody against the aquaporin-4 (AQP4) on astrocytes triggers the activation of the complement cascade, causing astrocyte injury, followed by oligodendrocyte injury, demyelination, and neuronal loss. Complement C3 is positioned as a central player that relays upstream initiation signals to activate downstream effectors, potentially stimulating and amplifying host immune and inflammatory responses. However, whether targeting the inhibition of C3 signaling could ameliorate tissue injury, locomotor defects, and visual impairments in NMO remains to be investigated. In this study, using the targeted C3 inhibitor CR2-Crry led to a significant decrease in complement deposition and demyelination in both slice cultures and focal intracerebral injection models. Moreover, the treatment downregulated the expression of inflammatory cytokines and improved motor dysfunction in a systemic NMO mouse model. Similarly, employing serotype 2/9 adeno-associated virus (AAV2/9) to induce permanent expression of CR2-Crry resulted in a reduction in visual dysfunction by attenuating NMO-like lesions. Our findings reveal the therapeutic value of inhibiting the complement C3 signaling pathway in NMO.

摘要

视神经脊髓炎(NMO)是一种中枢神经系统(CNS)自身免疫性炎症性疾病,其特征为横贯性脊髓炎和视神经炎。针对星形胶质细胞上水通道蛋白-4(AQP4)的致病性血清 IgG 抗体触发补体级联反应的激活,导致星形胶质细胞损伤,随后是少突胶质细胞损伤、脱髓鞘和神经元丢失。补体 C3 被定位为一个核心参与者,它将上游起始信号传递给下游效应物,可能刺激和放大宿主的免疫和炎症反应。然而,靶向抑制 C3 信号是否能改善 NMO 中的组织损伤、运动缺陷和视力障碍仍有待研究。在这项研究中,使用靶向 C3 抑制剂 CR2-Crry 导致切片培养和局灶性脑内注射模型中补体沉积和脱髓鞘显著减少。此外,该治疗方法下调了炎症细胞因子的表达,并改善了全身性 NMO 小鼠模型中的运动功能障碍。同样,利用血清型 2/9 腺相关病毒(AAV2/9)诱导 CR2-Crry 的永久性表达,通过减轻类似 NMO 的病变来减少视觉功能障碍。我们的研究结果揭示了抑制 NMO 中补体 C3 信号通路的治疗价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5a/10492028/9261655932dd/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5a/10492028/9261655932dd/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5a/10492028/9261655932dd/fx1.jpg

相似文献

1
Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases.抑制补体 C3 信号转导可改善自身免疫性炎症疾病的运动和视觉功能障碍。
Mol Ther. 2023 Sep 6;31(9):2715-2733. doi: 10.1016/j.ymthe.2023.07.017. Epub 2023 Jul 22.
2
Astrocyte-secreted C3 signaling impairs neuronal development and cognition in autoimmune diseases.星形细胞分泌的 C3 信号会损害自身免疫性疾病中的神经元发育和认知。
Prog Neurobiol. 2024 Sep;240:102654. doi: 10.1016/j.pneurobio.2024.102654. Epub 2024 Jun 28.
3
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.基于向大鼠脑脊液中慢性注入自身抗体的视神经脊髓炎研究模型。
J Neuroinflammation. 2016 May 18;13(1):111. doi: 10.1186/s12974-016-0577-8.
4
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.C1q 靶向单克隆抗体可预防视神经脊髓炎的体外和小鼠模型中的补体依赖性细胞毒性和神经病理学。
Acta Neuropathol. 2013 Jun;125(6):829-40. doi: 10.1007/s00401-013-1128-3. Epub 2013 May 16.
5
Optic neuritis in neuromyelitis optica.视神经脊髓炎中的视神经炎。
Prog Retin Eye Res. 2013 Sep;36:159-71. doi: 10.1016/j.preteyeres.2013.03.001. Epub 2013 Mar 30.
6
Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.视神经脊髓炎中补体引发的早期少突胶质细胞损伤的旁观者机制
Acta Neuropathol. 2017 Jul;134(1):35-44. doi: 10.1007/s00401-017-1734-6. Epub 2017 May 31.
7
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.自身免疫性星形胶质细胞病的病理学:视神经脊髓炎得到的启示。
Brain Pathol. 2014 Jan;24(1):83-97. doi: 10.1111/bpa.12099.
8
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica.补体依赖性旁观者神经元损伤在水通道蛋白 4 免疫球蛋白 G 阳性视神经脊髓炎中。
J Neuroinflammation. 2018 Oct 22;15(1):294. doi: 10.1186/s12974-018-1333-z.
9
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
10
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.视神经脊髓炎谱系疾病:从病理生理学到治疗策略。
J Neuroinflammation. 2021 Sep 16;18(1):208. doi: 10.1186/s12974-021-02249-1.

引用本文的文献

1
Induction of immune tolerance in NMOSD and MOGAD.在视神经脊髓炎谱系障碍(NMOSD)和髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)中诱导免疫耐受。
Ther Adv Neurol Disord. 2025 Aug 1;18:17562864251357393. doi: 10.1177/17562864251357393. eCollection 2025.
2
Plasma complement proteins as biomarkers and therapeutic targets in chronic kidney disease: a Mendelian randomization analysis.血浆补体蛋白作为慢性肾脏病的生物标志物和治疗靶点:孟德尔随机化分析
Ren Fail. 2025 Dec;47(1):2525473. doi: 10.1080/0886022X.2025.2525473. Epub 2025 Jul 17.
3
Activation of the C3 Complement Pathway in the Hippocampus Produces Anxiodepressive Effects in a Mouse Model of Inflammation Pain.

本文引用的文献

1
T follicular helper cells contribute to pathophysiology in a model of neuromyelitis optica spectrum disorders.滤泡辅助 T 细胞有助于视神经脊髓炎谱系疾病模型中的病理生理学。
JCI Insight. 2023 Feb 22;8(4):e161003. doi: 10.1172/jci.insight.161003.
2
Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation.视神经脊髓炎谱系疾病中的髓鞘再生是通过依达拉奉通过 mTORC1 信号激活来促进的。
Glia. 2023 Feb;71(2):284-304. doi: 10.1002/glia.24271. Epub 2022 Sep 12.
3
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
海马体中C3补体途径的激活在炎症性疼痛小鼠模型中产生焦虑抑郁效应。
Mol Neurobiol. 2025 Jul 11. doi: 10.1007/s12035-025-05187-8.
4
AMY-101 as complement C3 inhibitor for periodontitis therapy: mechanisms, efficacy, and clinical translation.AMY-101作为用于牙周炎治疗的补体C3抑制剂:作用机制、疗效及临床转化
Front Immunol. 2025 Apr 29;16:1587126. doi: 10.3389/fimmu.2025.1587126. eCollection 2025.
5
Intravitreal delivery of NMO-IgG causes primary retinal damage in the absence of optic nerve injury.在没有视神经损伤的情况下,玻璃体内注射视神经脊髓炎免疫球蛋白(NMO-IgG)会导致原发性视网膜损伤。
J Neuroinflammation. 2025 Mar 7;22(1):69. doi: 10.1186/s12974-025-03380-z.
6
Formation of Multinucleated Giant Cells after Experimental Intracerebral Hemorrhage: Characteristics and Role of Complement C3.实验性脑出血后多核巨细胞的形成:补体C3的特征与作用
Biomedicines. 2024 Jun 4;12(6):1251. doi: 10.3390/biomedicines12061251.
7
Neurodegeneration and demyelination in multiple sclerosis.多发性硬化中的神经退行性变和脱髓鞘。
Neuron. 2024 Oct 9;112(19):3231-3251. doi: 10.1016/j.neuron.2024.05.025. Epub 2024 Jun 17.
8
Complement-targeted therapy for autoimmune diseases.针对自身免疫性疾病的补体靶向治疗。
Med Rev (2021). 2024 Jan 4;3(6):521-525. doi: 10.1515/mr-2023-0051. eCollection 2023 Dec.
视神经脊髓炎谱系疾病:从病理生理学到治疗策略。
J Neuroinflammation. 2021 Sep 16;18(1):208. doi: 10.1186/s12974-021-02249-1.
4
Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury.补体在创伤性脑损伤后延长的慢性时间点介导神经炎症和认知下降。
Acta Neuropathol Commun. 2021 Apr 20;9(1):72. doi: 10.1186/s40478-021-01179-6.
5
Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury.诱导性神经干细胞移植通过 Crry 和 Akt 在闭合性颅脑损伤小鼠模型中的相互作用发挥神经保护作用。
Stem Cell Res Ther. 2021 Feb 12;12(1):128. doi: 10.1186/s13287-021-02186-z.
6
Targeting the complement system in neuromyelitis optica spectrum disorder.靶向视神经脊髓炎谱系疾病中的补体系统。
Expert Opin Biol Ther. 2021 Aug;21(8):1073-1086. doi: 10.1080/14712598.2021.1884223. Epub 2021 Feb 16.
7
Transneuronal delivery of hyper-interleukin-6 enables functional recovery after severe spinal cord injury in mice.经神经元传递超白细胞介素-6 可促进小鼠严重脊髓损伤后的功能恢复。
Nat Commun. 2021 Jan 15;12(1):391. doi: 10.1038/s41467-020-20112-4.
8
Complement in neurological disorders and emerging complement-targeted therapeutics.神经疾病中的补体及新兴的补体靶向疗法。
Nat Rev Neurol. 2020 Nov;16(11):601-617. doi: 10.1038/s41582-020-0400-0. Epub 2020 Oct 1.
9
Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.美金刚改善视神经脊髓炎谱系障碍小鼠模型中的运动障碍和病理变化。
J Neuroinflammation. 2020 Aug 11;17(1):236. doi: 10.1186/s12974-020-01913-2.
10
Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth.补体抑制因子 Crry 在小鼠胎盘的表达对于维持正常血压和胎儿生长至关重要。
PLoS One. 2020 Aug 3;15(8):e0236968. doi: 10.1371/journal.pone.0236968. eCollection 2020.